NCT06544148 Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study
| NCT ID | NCT06544148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Condition | Pulmonary Artery Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 28 participants |
| Start Date | 2024-08-05 |
| Primary Completion | 2026-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 28 participants in total. It began in 2024-08-05 with a primary completion date of 2026-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess whether changes in electrical impedance - measured using an electrical impedance tomography (EIT) chest belt - can be used to derive changes in pulmonary artery pressure (PAP) in critically ill patients when compared to invasive gold-standard PAP measured using pulmonary artery catheter (PAC).
Eligibility Criteria
Inclusion criteria: * Age ≥ 18-year-old. * Intubated patients in the ICU with clinical decision to monitor PAP and cardiac output using a PAC. Exclusion criteria: * Patients with implanted or external thoracic electronic devices (e.g., pacemaker) or thoracic metal implants. * Known pregnancy or lactating patients. * Open lung injuries or pneumothorax. * Open wounds, drainages, burns or rashes of the upper thorax. * Estimated thoracic perimeter smaller than 66 cm or larger than 134 cm. * Known allergies to wound dressings or adhesives (e.g., gel electrodes)
Contact & Investigator
Kaspar F Bachmann, MD
PRINCIPAL INVESTIGATOR
Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Frequently Asked Questions
Who can join the NCT06544148 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Artery Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06544148 currently recruiting?
Yes, NCT06544148 is actively recruiting participants. Contact the research team at kaspar.bachmann@faculty.unibe.ch for enrollment information.
Where is the NCT06544148 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT06544148 clinical trial?
NCT06544148 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Kaspar F Bachmann, MD at Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. The trial plans to enroll 28 participants.